Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Lansoprazole decreases IL-4-stimulated eotaxin-3 protein secretion in (A) EoE1-T and (2) EoE2-T cells. by Xi Zhang (83736)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

IFN-β mRNA induction but IFN protein decrease in all mammalian cells upon ONNV infection. by Susanne E. Biesold (194461)

“…(E) Comparison of mRNA fold-induction of IFN stimulated genes (<i>MxA</i> and <i>ISG56</i>) to secreted IFN protein at time points 0 hpi and 24 hpi. …”

Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

Overexpressions of the AB domain of RPA70 and the β-barrel domain of Ku70 significantly decrease HBoV1 replication in HAE-ALI. by Kang Ning (59789)

“…Duplex HBoV1 genome was loaded as a size marker (M) of 5.5 kb. …”

PLCε depletion leads to decreased basal Rap1 activity, which drives monolayer leak. by Peter V. DiStefano (3111639)

A prepubertal CD decreases hepatic lipid accumulation in adulthood despite a chronic HFD in Sprague-Dawley male rats. by Ana Aguilar-Lozano (20614619)

Decrease in the HS4C3-binding epitope inhibits differentiation and apoptosis. by Kazumi Hirano (144477)

p63^TECko mice have decreased TECs and DN1 cells in embryonic mice. by Heather E. Stefanski (5058746)

<i>S.</i> Typhimurium-infected mice have tissue inflammation and thrombosis, increased hematopoiesis, and decreased splenic iron. by Diane E. Brown (160264)

“…(B) Mouse spleen, 3 weeks post-infection; extramedullary hematopoiesis (EMH; arrow, megakaryocytes), histiocytic infiltration (I) throughout the red pulp, and thrombus (T). H&E stain (A, B). (C) Spleen, mock-infected (left) and infected mouse (right), 3 weeks post-infection; markedly decreased ferric iron staining in red pulp. …”

Construction and optimisation of a SARS-CoV-2 protein antigen microarray and fractionation of serum immunoglobulins. by Marie Le Berre (6299012)

<i>jun-1</i> mutants are highly susceptible to both Bt strains, while <i>elt-2</i> silencing decreased survival on Bt679 but increased survival on Bt247. by Alejandra Zárate-Potes (9415842)

Decrease in cell viability by siRNA and miRNA dependent induction of DTA. by Liraz Harel (675561)

“…P value for the construct with target sites for miRNAs 21-5p, 125b-5p, 1273g-5p was 1.2*e(−10).</p>…”

The <i>E</i>. <i>multilocularis</i> antigen-specific IgG reactivity (OD) in alveolar echinococcosis (AE) patients and infection-free controls. by Beate Grüner (301524)

Subjects:

AIM-100 reduces dsRNA silencing in body wall muscle and decreases DA neurodegeneration. by Anthony L. Gaeta (13272609)